Jale Muslehiddinoglu

Stereoselective Bulk Synthesis of CCR2 Antagonist BMS-741672: Assembly of an All-cis (S,R,R)-1,2,4-Triaminocyclohexane (TACH) Core via Sequential Heterogeneous Asymmetric Hydrogenations

Richard L. Schild, Martin D. Eastgate, S. Leung, 2016 .

The Process Development of Ravuconazole: An Efficient Multikilogram Scale Preparation of an Antifungal Agent(1)

J. Wasylak, S. Leung, Chien-Kuang Chen, 2009 .

Development of a Continuous Plug Flow Process for Preparation of a Key Intermediate for Brivanib Alaninate

Steven H. Chan, T. LaPorte, Paul C. Lobben, 2014 .

The Development of a Scalable, Chemoselective Nitro Reduction

R. Livingston, W. P. Gallagher, Jale Muslehiddinoglu, 2012 .

Control Strategy for the Manufacture of Brivanib Alaninate, a Novel Pyrrolotriazine VEGFR/FGFR Inhibitor

David K. Leahy, Sushil K. Srivastava, T. LaPorte, 2015 .

Highly Diastereoselective Hydrogenation of Imines by a Bimetallic Pd−Cu Heterogeneous Catalyst

S. Tummala, Jun Li, Jale Muslehiddinoglu, 2010 .

Development of a Practical Synthesis of a Functionalized Pyrrolo[2,1-f][1,2,4]triazine Nucleus

J. Burt, D. Conlon, W. P. Gallagher, 2012 .

Technical Considerations for Use of Oligonucleotide Solution API

Malcolm L Hill, Jale Muslehiddinoglu, Robert Simler, 2020, Nucleic acid therapeutics.